HomeFPSUF • OTCMKTS
add
Capha Pharmaceuticals Inc.
Previous close
$0.00
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.52K | -27.79% |
Net income | -14.73K | 26.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.44K | 28.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.38K | 169.94% |
Total assets | 4.41K | 64.10% |
Total liabilities | 598.58K | 11.29% |
Total equity | -594.18K | — |
Shares outstanding | 64.43M | — |
Price to book | -0.00 | — |
Return on assets | -845.52% | — |
Return on capital | 219.29% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -14.73K | 26.91% |
Cash from operations | -27.50K | 18.09% |
Cash from investing | — | — |
Cash from financing | 29.50K | -10.61% |
Net change in cash | 2.00K | 446.88% |
Free cash flow | -19.35K | 14.13% |
About
Headquarters
